Condition: Atopic Dermatitis
Intervention: Biological: Nemolizumab
Sponsor: Galderma R&D
Not yet recruiting
ClinicalTrials.gov: Musculoskeletal | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days
April 21, 2019ClinicalTrials.govComments OffMusculoskeletalAdolescent | Atopic | Dermatitis | Nemolizumab | Pharmacokinetics | Safety | Study | Subjects
